A total of 545 results found based on your keywords
| RF_ID | Disease Name | poly_category | variablesites | Species | RF_Name | Association | Condition | PMID |
|---|---|---|---|---|---|---|---|---|
| 2204 | Alzheimer's Disease | Other polymorphisms | TMEM88B P45L | Human | TMEM | RF | APOE-?2 | 33576571 |
| 4016 | Amyotrophic Lateral Sclerosis | Other polymorphisms | 39 CAG repeats in exon 1 | Human | HTT | RF | 36599142 | |
| 3986 | Amyotrophic Lateral Sclerosis | Other polymorphisms | rare hypermorphic SARM1 alleles | human and mice | SARM1 | RF | 34991663 | |
| 2021 | Parkinson disease | Other polymorphisms | 120 bp duplicated allele | Human | DRD4 | RF | 35532648 | |
| 2090 | Parkinson disease | Other polymorphisms | homozygous genotype | Human | DRD4 | RF | 35532648 | |
| 2220 | Alzheimer's Disease | Other polymorphisms | G1958A A allele | Human | 5, 10-methylenetetrahydrofolate dehydrogenase gene (MTHFD1) | RF | 20217437 | |
| 2267 | Alzheimer's Disease | Other polymorphisms | Human | 5-HTT | RF | homozygous low activity genotype: ε4 alleles of the ApoE gene | 9106747 | |
| 2305 | Alzheimer's Disease | Other polymorphisms | Human | 5-LO | RF | A allele | 20110601 | |
| 3150 | Alzheimer's Disease | Other polymorphisms | rs3764650 polymorphism | Human | ABCA7 | RF | with both ApoEε4-carrier and aging being factors enhancing its risk | 24113560 |
| 3148 | Alzheimer's Disease | Other polymorphisms | Human | ABCA7 | RF | 29589097 | ||
| 2986 | Alzheimer's Disease | Other polymorphisms | G1430S | Human | ABCA8 | RF | APOE-?2 | 33576571 |
| 2900 | Alzheimer's Disease | Other polymorphisms | C1244Y | Human | ABCA8 | RF | APOE-?2 | 33576571 |
| 2495 | Alzheimer's Disease | Other polymorphisms | Human | ACE | RF | 11078932 | ||
| 2023 | Parkinson disease | Other polymorphisms | Deletion/insertion polymorphism | Human | ACE | RF | 12084438 | |
| 2022 | Parkinson disease | Other polymorphisms | Deletion/insertion polymorphism | Human | ACE | RF | 12084438 | |
| 1894 | Alzheimer's Disease | Other polymorphisms | -17(A > T) polymorphisms | Human | ACT | RF | A allele carriers are associated with increased susceptibility to AD in variant populations | 22272609 |
| 3154 | Multiple System Atrophy | Other polymorphisms | ACT-AA genotype | Human | ACT | RF | 15907346 | |
| 1897 | Alzheimer's Disease | Other polymorphisms | -17(A > T) polymorphisms | Human | ACT | RF | A allele carriers are associated with increased susceptibility to AD in variant populations | 22272609 |
| 1976 | Alzheimer's Disease | Other polymorphisms | A allele | Human | ACT | RF | especially in Caucasians | 22294107 |
| 1896 | Alzheimer's Disease | Other polymorphisms | AA genotype | Human | ACT | RF | especially in Caucasians | 22294107 |
| 2889 | Parkinson disease | Other polymorphisms | C allele of rs514049 | Human | ADAM10 | RF | 33527480 | |
| 512 | Alzheimer's Disease | Other polymorphisms | rs2241894 TT genotype | Human | ADH1C | PF | 33551739 | |
| 3811 | Lewy Body Disease | Other polymorphisms | Human | AD-PRS | RF | 34308904 | ||
| 756 | Alzheimer's Disease | Other polymorphisms | L352V | Human | AKNAD1 | PF | APOE-?3 | 33576571 |
| 1951 | Alzheimer's Disease | Other polymorphisms | G582V | Human | AKNAD1 | RF | APOE-?3 | 33576571 |
| 2337 | Alzheimer's Disease | Other polymorphisms | L352V | Human | AKNAD1 | RF | APOE-?2 | 33576571 |
| 2803 | Alzheimer's Disease | Other polymorphisms | 2 allele | Human | ALDH2 | RF | dependent on APOE epsilon4 status in Chinese | 18201725 |
| 691 | Alzheimer's Disease | Other polymorphisms | P182L | Human | ALDH5A1 | PF | APOE-?3 | 33576571 |
| 3158 | Alzheimer's Disease | Other polymorphisms | Rs7659, 3' UTR polymorphism | Human | APOD | RF | in APOEε4 (-) subgroup | 23690001 |
| 2449 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | APOE ε4ε4 | 25673977 | |
| 1643 | Alzheimer's Disease | Other polymorphisms | E4 alleles | Human | APOE | RF | 32767997 | |
| 3180 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 21637534 | |
| 2750 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 24281128 | |
| 3160 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | ε4 allele | 29592889 | |
| 3185 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 18560129 | |
| 2759 | Dementia with Lewy bodies | Other polymorphisms | ε4 | Human | APOE | RF | 30798004 | |
| 1761 | Alzheimer's Disease | Other polymorphisms | ε4 homozygote | Human | APOE | RF | 33397450 | |
| 2829 | Alzheimer's Disease | Other polymorphisms | ε4 genotype | Human | APOE | RF | 30894904 | |
| 3666 | Alzheimer's Disease | Other polymorphisms | E4 alleles | Human | APOE | RF | 32043803 | |
| 825 | Frontotemporal Dementia | Other polymorphisms | ε2 | Human | APOE | PF | 12107813 | |
| 521 | Frontotemporal Dementia | Other polymorphisms | ε2 | Human | APOE | PF | 15904995 | |
| 3166 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | ε4 allele | 7977635 | |
| 3191 | Alzheimer's Disease | Other polymorphisms | ?4 allele | Human | APOE | RF | ?4 allele | 23038715 |
| 2855 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | Carrying at least one ε4 allele; Calculated by Step-wise model | 10213175 | |
| 2606 | Creutzfeldt-Jakob disease | other polymorphisms | ε4 | Human | APOE | RF | ε4 allele | 7968026 |
| 2340 | Frontotemporal Lobar Degeneration | other polymorphisms | ε2 | Human | APOE | RF | ε2ε2 vs. ε3ε3+ε3ε2 | 28487499 |
| 3171 | Alzheimer's Disease | Other polymorphisms | ε3/4 genotype | Human | APOE | RF | 30890475 | |
| 2938 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 23871727 | |
| 2433 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | 12095653 | ||
| 2505 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | ε4 allele | 12160362 | |
| 2366 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | Gender: female; Calculated by Step-wise model | 10213175 | |
| 3139 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | lowers age at onset of LOAD significantly | 18416843 |
| 3177 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 26738348 | |
| 2728 | Frontotemporal Lobar Degeneration | other polymorphisms | ε4 | Human | APOE | RF | ε4ε4 vs. ε3ε3+ε3ε4 | 28487499 |
| 3082 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | 12095653 | ||
| 2646 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 22311091 | |
| 2753 | Frontotemporal Lobar Degeneration | other polymorphisms | Human | APOE | RF | ε4 allele | 23887281 | |
| 1679 | Parkinson disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 36348503 | |
| 3182 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | The rate of APOE4 carrier status and the frequency of the ε4 allele were 47% and 27% for LOAD, 50% and 31% for EOAD, | 21552550 |
| 2818 | Frontotemporal Lobar Degeneration | other polymorphisms | ε4 | Human | APOE | RF | ε4ε4 vs. ε3ε3 | 28487499 |
| 3162 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | ε4 allele | 7841371 | |
| 2957 | Alzheimer's Disease | Other polymorphisms | ε4 | Human | APOE | RF | 29307083 | |
| 2675 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | Genotype: ε3/4; adjusted for age and education, and stratified by gender | 30205398 | |
| 3188 | Dementia with Lewy bodies | Other polymorphisms | Human | APOE | RF | epsilon 4 allele | 7970234 | |
| 3044 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | PENN cohort; ε2 | 30128317 | |
| 1771 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 30450407 | |
| 602 | Alzheimer's Disease | Other polymorphisms | Human | APOE | PF | ε2 allele | 29990559 | |
| 2592 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | Genotype: ε4/-; adjusted for age and education, and stratified by gender | 30205398 | |
| 2929 | Alzheimer's Disease | Other polymorphisms | ε3/ε4 genotype | Human | APOE | RF | 23871727 | |
| 2143 | Frontotemporal Lobar Degeneration | other polymorphisms | ε4 | Human | APOE | RF | ε4 vs. ε2 allele model | 28487499 |
| 532 | Alzheimer's Disease | Other polymorphisms | Human | APOE | PF | ε3 allele | 29990559 | |
| 3168 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | 8993485 | ||
| 2272 | Frontotemporal Lobar Degeneration | other polymorphisms | ε4 | Human | APOE | RF | ε3ε4+ε4ε4 vs. ε3ε3 | 28487499 |
| 3193 | Frontotemporal Dementia | Other polymorphisms | ε2 | Human | APOE | RF | 28888721 | |
| 3065 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 22737475 | |
| 705 | Alzheimer's Disease | Other polymorphisms | -219 polymorphism G allele | Human | APOE | PF | 18317248 | |
| 2350 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | Genotype: ε3/4; adjusted for age and education, and stratified by gender | 30205398 | |
| 3174 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 27033052 | |
| 2697 | Frontotemporal Dementia | Other polymorphisms | ε4 allele | Human | APOE | RF | 15904995 | |
| 1331 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 20376800 | |
| 2289 | Frontotemporal Lobar Degeneration | other polymorphisms | ε2 | Human | APOE | RF | ε2ε2 vs. ε3ε3 | 28487499 |
| 2375 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | APOE ε3ε4 | 25673977 | |
| 3179 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 23887281 | |
| 3089 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | ε4 allele | 29990559 | |
| 2315 | Creutzfeldt-Jakob disease | other polymorphisms | ε4 | Human | APOE | RF | ε4 allele | 7968026 |
| 3159 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 22712640 | |
| 2654 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | Genotype: ε4/-; adjusted for age and education, and stratified by gender | 30205398 | |
| 2755 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | National Alzheimer’s Coordinating Center (NACC) cohort; ε2 | 30128317 | |
| 1722 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 21649613 | |
| 3184 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 20385913 | |
| 822 | Alzheimer's Disease | Other polymorphisms | e3 allele | Human | APOE | PF | 22068907 | |
| 520 | Frontotemporal Lobar Degeneration | other polymorphisms | Human | APOE | PF | ε2 allele | 15904995 | |
| 3164 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | ε2 allele | 29562509 | |
| 3190 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | APOE haplotypes | 24596166 | |
| 2851 | Dementia with Lewy bodies | Other polymorphisms | ε4 allele | Human | APOE | RF | 12411758 | |
| 2339 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 19819468 | |
| 2936 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 20217437 | |
| 542 | Alzheimer's Disease | Other polymorphisms | ε2 allele | Human | APOE | PF | 18317248 | |
| 3170 | Alzheimer's Disease | Other polymorphisms | ε4 genotype | Human | APOE | RF | 30991302 | |
| 571 | Alzheimer's Disease | Other polymorphisms | e3 allele | Human | APOE | PF | ε3 allele | 24632849 |
| 3176 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | The ε4 allele increases the risk of Alzheimer's disease by 5.114 times | 26835020 |
| 3015 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | Carrying at least one ε4 allele | 10213175 | |
| 2717 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | Genotype: AA | 10213175 | |
| 1669 | Alzheimer's Disease | Other polymorphisms | ε4 heterozygote | Human | APOE | RF | 33397450 | |
| 3181 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | 21556001 | ||
| 500 | Alzheimer's Disease | Other polymorphisms | Human | APOE | PF | PENN cohort; ε4 | 30128317 | |
| 3161 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | ε4 allele | 30112972 | |
| 2906 | Alzheimer's Disease | Other polymorphisms | ε4 | Human | APOE | RF | ε4 allele | 24632849 |
| 3186 | Frontotemporal Dementia | Other polymorphisms | ε4 allele | Human | APOE | RF | 23887281 | |
| 3042 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | Genotype: ε4/4; adjusted for age and education, and stratified by gender | 30205398 | |
| 2480 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | APOE ε4 | 10912224 | |
| 2231 | Frontotemporal Lobar Degeneration | other polymorphisms | ε4 | Human | APOE | RF | ε4 vs. ε3 allele model | 28487499 |
| 1762 | Alzheimer's Disease | Other polymorphisms | E4 alleles | Human | APOE | RF | 32485802 | |
| 2844 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | Carrying at least one ε4 allele; Calculated by Forced entry model | 10213175 | |
| 3667 | Alzheimer's Disease | Other polymorphisms | E4 alleles | Human | APOE | RF | 32116259 | |
| 2140 | Alzheimer's Disease | Other polymorphisms | -219 polymorphism T allele | Human | APOE | RF | 18317248 | |
| 826 | Frontotemporal Dementia | Other polymorphisms | ε4 | Human | APOE | PF | 28888721 | |
| 527 | Alzheimer's Disease | Other polymorphisms | Human | APOE | PF | National Alzheimer’s Coordinating Center (NACC) cohort; ε4 | 30128317 | |
| 3167 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | 9008509 | ||
| 2982 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | ε4 allele; associated with homozygosity | 8128961 | |
| 3192 | Progressive Supranuclear Palsy | Other polymorphisms | ε4 allele | Human | APOE | RF | 12552038 | |
| 2857 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 20682755 | |
| 2348 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 18446027 | |
| 697 | Alzheimer's Disease | Other polymorphisms | Human | APOE | PF | APOEε2ε3 | 25673977 | |
| 3172 | Alzheimer's Disease | Other polymorphisms | ε3/4 andε4/4 genotypes,ε4 allele | Human | APOE | RF | 28461186 | |
| 2939 | Creutzfeldt-Jakob disease | other polymorphisms | ε4 | Human | APOE | RF | ε4 allele | 7968026 |
| 2696 | Frontotemporal Lobar Degeneration | other polymorphisms | Human | APOE | RF | ε4 allele | 15904995 | |
| 2509 | Dementia with Lewy bodies | Other polymorphisms | Human | APOE | RF | 4 allele | 16956959 | |
| 2208 | Frontotemporal Lobar Degeneration | other polymorphisms | ε4 | Human | APOE | RF | ε3ε4 vs. ε3ε3 | 28487499 |
| 3178 | Alzheimer's Disease | Other polymorphisms | -491T allele | Human | APOE | RF | 24326531 | |
| 3086 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | ε4 allele | 11376902 | |
| 2807 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | Genotype: ε4/-; adjusted for age and education, and stratified by gender | 30205398 | |
| 2522 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | Genotype: ε3/4; adjusted for age and education, and stratified by gender | 30205398 | |
| 2898 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | Individuals with 2 epsilon 4 alleles had a higher risk for AD than subjects with only 1 such allele | 18317248 |
| 2754 | Frontotemporal Dementia | Other polymorphisms | ε4 | Human | APOE | RF | 23887281 | |
| 1717 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 24045327 | |
| 3183 | Alzheimer's Disease | Other polymorphisms | e3 | human and mice | APOE | RF | nutritional imbalance | 20413864 |
| 3023 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | Genotype: ε4/4; adjusted for age and education, and stratified by gender | 30205398 | |
| 2823 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | at least one epsilon 4 allele | 8786847 | |
| 2126 | Frontotemporal Lobar Degeneration | other polymorphisms | ε4 | Human | APOE | RF | ε4 vs. ε2+ε3+ε4 carrier model | 28487499 |
| 3163 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | ε2 allele | 7824157 | |
| 3189 | Dementia with Lewy bodies | Other polymorphisms | ε4 allele | Human | APOE | RF | The rate of APOE4 carrier status and the frequency of the ε4 allele were 42% and 31% for DLB | 21552550 |
| 2847 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | Th1/E47cs polymorphism allele | 12095653 | |
| 2146 | Frontotemporal Lobar Degeneration | other polymorphisms | ε4 | Human | APOE | RF | ε4 vs. ε2+ε3+ε4 allele model | 28487499 |
| 3169 | Alzheimer's Disease | Other polymorphisms | -427C | Human | APOE | RF | 9811931 | |
| 1848 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 22068907 | |
| 3194 | Dementia with Lewy bodies | Other polymorphisms | ε4 | Human | APOE | RF | 27312774 | |
| 2864 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | ε4 allele; associated with heterozygosity | 8128961 | |
| 2356 | Alzheimer's Disease | Other polymorphisms | Human | APOE | RF | Gender: female; Calculated by Forced entry model | 10213175 | |
| 3175 | Alzheimer's Disease | Other polymorphisms | ε4 allele | Human | APOE | RF | 26885125 | |
| 562 | Dementia with Lewy bodies | Other polymorphisms | ε2 | Human | APOE | PF | 30798004 | |
| 3080 | Alzheimer's Disease | Other polymorphisms | ε4 | Human | APOE | RF | 29348964 | |
| 620 | Alzheimer's Disease | Other polymorphisms | Human | APOE ε2/ε3 | PF | 28846757 | ||
| 732 | Alzheimer's Disease | Other polymorphisms | Human | APOE ε2/ε3 | PF | 28846757 | ||
| 2828 | Alzheimer's Disease | Other polymorphisms | Human | APOE ε3/ε4 | RF | from ages 55 to 85 years | 28846757 | |
| 2794 | Alzheimer's Disease | Other polymorphisms | Human | APOE ε3/ε4 | RF | from ages 55 to 85 years | 28846757 | |
| 2793 | Alzheimer's Disease | Other polymorphisms | Human | ApoE ε4/ε3 | RF | ε4/ε3 genotype | 24632849 | |
| 2435 | Alzheimer's Disease | Other polymorphisms | Human | ApoE ε4/ε4 | RF | ε4/ε4 genotype | 24632849 | |
| 2813 | Alzheimer's Disease | Other polymorphisms | Human | APOE,ACT | RF | ACT Genotype: AT; One Copy of ε4 | 8993481 | |
| 2657 | Alzheimer's Disease | Other polymorphisms | Human | APOE,ACT | RF | ACT Genotype: TT; One Copy of ε4 | 8993481 | |
| 2811 | Alzheimer's Disease | Other polymorphisms | Human | APOE,ACT | RF | ACT Genotype: TT; Two Copies of ε4 | 8993481 | |
| 2915 | Alzheimer's Disease | Other polymorphisms | Human | APOE,ACT | RF | ACT Genotype: AA; Two Copies of ε4 | 8993481 | |
| 3114 | Alzheimer's Disease | Other polymorphisms | Human | APOE,ACT | RF | ACT Genotype: AT; Two Copies of ε4 | 8993481 | |
| 2946 | Alzheimer's Disease | Other polymorphisms | Human | APOE,ACT | RF | ACT Genotype: AA; One Copy of ε4 | 8993481 | |
| 2510 | Frontotemporal Lobar Degeneration | other polymorphisms | Human | APOE,TOMM40 | RF | APOE-TOMM40 haplotype: ε4 GAC | 23546992 | |
| 2439 | Parkinson disease | Other polymorphisms | rs7412、rs429358 | Human | APOE?4 | RF | 33057949 | |
| 3195 | Dementia with Lewy bodies | Other polymorphisms | Human | APP | RF | 27312774 | ||
| 513 | Alzheimer's Disease | Other polymorphisms | R797H;R772H | Human | ARHGAP33 | PF | APOE-?3 | 33576571 |
| 3197 | Amyotrophic Lateral Sclerosis | other polymorphisms | Human | ATAXIN2 | RF | ≥ 31 CAG-repeat length | 22425256 | |
| 3668 | Parkinson disease | Other polymorphisms | Human | ATP10B | RF | recessive loss of function mutations | 32172343 | |
| 2640 | Alzheimer's Disease | Other polymorphisms | A30T | Human | ATP6V0E2 | RF | APOE-?2 | 33576571 |
| 2417 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | ATRN | RF | 27455347 | ||
| 3038 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Expanded glutamine repeats of the ataxin-2 protein | Human | ATXN2 | RF | CAG repeat length >30 | 21610160 |
| 3113 | Amyotrophic Lateral Sclerosis | other polymorphisms | Human | ATXN2 | RF | ATXN2 high-length alleles (≥29 CAG repeats) | 21670397 | |
| 2991 | Amyotrophic Lateral Sclerosis | other polymorphisms | Human | ATXN2 | RF | ATXN2 high-length alleles (≥29 CAG repeats) | 21670397 | |
| 3202 | Frontotemporal Dementia | Other polymorphisms | Human | ATXN2 | RF | ATXN2 intermediary polyQ expansions | 25098532 | |
| 3073 | Amyotrophic Lateral Sclerosis | Other polymorphisms | CAG (polyQ) expansions of ≤30 versus ?≥31 | Human | ATXN2 | RF | 35521889 | |
| 2176 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Expanded glutamine repeats of the ataxin-2 (ATXN2) protein | Human | ATXN2 | RF | CAG repeat length >26 | 21610160 |
| 3201 | Amyotrophic Lateral Sclerosis | other polymorphisms | Human | ATXN2 | RF | ATXN2 polyQ repeat expansions greater than 27 | 21741123 | |
| 2778 | Amyotrophic lateral sclerosis with frontotemporal dementia | Other polymorphisms | CAG (polyQ) expansions of ≤30 versus ?≥31 | Human | ATXN2 | RF | 35521889 | |
| 2700 | Frontotemporal Dementia | Other polymorphisms | CAG (polyQ) expansions of ≤30 versus ?≥31 | Human | ATXN2 | RF | 35521889 | |
| 2323 | Alzheimer's Disease | Other polymorphisms | R158H | Human | AZU1 | RF | APOE-?2 | 33576571 |
| 659 | Alzheimer's Disease | Other polymorphisms | R51G | Human | B3GAT2 | PF | APOE-?3 | 33576571 |
| 2107 | Alzheimer's Disease | Other polymorphisms | exon5 C/G polymorphism CC genotype | Human | BACE1 | RF | with APOEε4 carrier status | 26550136 |
| 592 | Alzheimer's Disease | Other polymorphisms | P198S;P336S;P198S;P360S;P198S;P80S;P384S | Human | BCL2L13 | PF | APOE-?2 | 33576571 |
| 2948 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | BIRC6 | RF | 27455347 | ||
| 744 | Alzheimer's Disease | Other polymorphisms | K652R | Human | BMS1 | PF | APOE-?3 | 33576571 |
| 2441 | Alzheimer's Disease | Other polymorphisms | Q84X | Human | C1orf185 | RF | APOE-?2 | 33576571 |
| 2865 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | C1QTNF7 | RF | 27455347 | ||
| 828 | Alzheimer's Disease | Other polymorphisms | Human | C282Y HFE | PF | 19429178 | ||
| 3978 | Amyotrophic Lateral Sclerosis | Other polymorphisms | short tandem repeat (STR) in C9orf72 | Human | C9orf72 | RF | 36511680 | |
| 2875 | Parkinson disease | Other polymorphisms | G4 C2 Intermediate repeats (20-60 repeats) | Human | C9orf72 | RF | 34440384 | |
| 2447 | Amyotrophic Lateral Sclerosis | Other polymorphisms | hexanucleotide repeat intermediate-length alleles | Human | C9orf72 | RF | 33168078 | |
| 3027 | Amyotrophic Lateral Sclerosis | Other polymorphisms | hexanucleotide repeat intermediate-length alleles | Human | C9orf72 | RF | 33168078 | |
| 2274 | Parkinson disease | Other polymorphisms | risk-haplotype | Human | C9orf72 | RF | 34440384 | |
| 2751 | Alzheimer's Disease | Other polymorphisms | intermediate repeat units | Human | C9orf72 | RF | 33935096 | |
| 3208 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | C9orf72 | RF | 29528390 | ||
| 3669 | Amyotrophic Lateral Sclerosis | Other polymorphisms | loss-of-function of Cav3.2 channels associated with rare CACNA1H variants | Human | CACNA1H | RF | 32143681 | |
| 3100 | Alzheimer's Disease | Other polymorphisms | Q229X | Human | CALHM2 | RF | APOE-?3 | 33576571 |
| 2281 | Parkinson disease | Other polymorphisms | R702W, G908R, L1007fs | Human | CARD15 | RF | 17174426 | |
| 2926 | Alzheimer's Disease | Other polymorphisms | G398D | Human | CCDC60 | RF | APOE-?2 | 33576571 |
| 1985 | Parkinson disease | Other polymorphisms | pCD14 polymorphism | Human | CD14 | RF | 16337421 | |
| 3211 | Parkinson disease | Other polymorphisms | rat | CD157/BST1 | RF | 24795584 | ||
| 3212 | Alzheimer's Disease | Other polymorphisms | Human | CD163L1 | RF | 29177109 | ||
| 3670 | Creutzfeldt-Jakob disease | Other polymorphisms | Human | Cerebroside sulfotransferase (GAL3ST1) | RF | 32565065 | ||
| 3214 | Alzheimer's Disease | Other polymorphisms | 2384 A allele | Human | CHAT | RF | 18562794 | |
| 3216 | Parkinson disease | Other polymorphisms | Pro2Leu variant | Human | CHCHD2 | RF | 27626775 | |
| 3215 | Dementia with Lewy bodies | Other polymorphisms | Human | CHCHD2 | RF | 26561290 | ||
| 3227 | Alzheimer's Disease | Other polymorphisms | Human | CLECL1 | RF | 29177109 | ||
| 2326 | Alzheimer's Disease | Other polymorphisms | A961V | Human | CNGB1 | RF | APOE-?2 | 33576571 |
| 2410 | Alzheimer's Disease | Other polymorphisms | L745I | Human | CNGB1 | RF | APOE-?2 | 33576571 |
| 2684 | Alzheimer's Disease | Other polymorphisms | G238S | Human | CNGB1 | RF | APOE-?2 | 33576571 |
| 2683 | Alzheimer's Disease | Other polymorphisms | V535A | Human | CNGB1 | RF | APOE-?2 | 33576571 |
| 2228 | Parkinson disease | Other polymorphisms | -108Met/Val polymorphism | Human | COMT | RF | 9503277 | |
| 2324 | Alzheimer's Disease | Other polymorphisms | COMT Met allele | Human | COMT | RF | without APOE ε4 allele carriers | 24575113 |
| 3002 | Alzheimer's Disease | Other polymorphisms | COMT Met allele | Human | COMT | RF | without APOE ε4 allele carriers;in men | 24575113 |
| 2868 | Alzheimer's Disease | Other polymorphisms | Val/Met genotype polymorphisms | Human | COMT | RF | 33900525 | |
| 3005 | Alzheimer's Disease | Other polymorphisms | Val/Val genotype polymorphisms | Human | COMT | RF | 33900525 | |
| 3228 | Multiple System Atrophy | Other polymorphisms | L25V variant | Human | COQ2 | RF | 27123473 | |
| 673 | Alzheimer's Disease | Other polymorphisms | V223G;S228A | Human | COX11 | PF | APOE-?2 | 33576571 |
| 2125 | Alzheimer's Disease | Other polymorphisms | Human | COX-2 | RF | G allele | 20110601 | |
| 2100 | Alzheimer's Disease | Other polymorphisms | Human | COX-2 | RF | GG allele | 20110601 | |
| 2403 | Alzheimer's Disease | Other polymorphisms | I66V | Human | CPT1B | RF | APOE-?2 | 33576571 |
| 3077 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | CREB3L2 | RF | 27455347 | ||
| 688 | Alzheimer's Disease | Other polymorphisms | S72N | Human | CRTC3 | PF | APOE-?2 | 33576571 |
| 2257 | Frontotemporal Lobar Degeneration | other polymorphisms | Human | CST3 | RF | negative for the presence of PGRN mutations;AB/BB genotypes | 19674067 | |
| 2206 | Frontotemporal Lobar Degeneration | other polymorphisms | Human | CST3 | RF | negative for the presence of PGRN mutations;haplotype B | 19674067 | |
| 2532 | Alzheimer's Disease | Other polymorphisms | Human | CST3 | RF | Caucasians | 10993992 | |
| 3081 | Alzheimer's Disease | Other polymorphisms | Human | CST3 | RF | CST3-A allele; Non-APOE ε4 carrier | 11711204 | |
| 2572 | Alzheimer's Disease | Other polymorphisms | Human | CST3 | RF | CST3-A allele; APOE ε4 carrier | 11711204 | |
| 3229 | Alzheimer's Disease | Other polymorphisms | Human | CTNNA1 | RF | 29177109 | ||
| 2485 | Alzheimer's Disease | Other polymorphisms | S53G | Human | CTSB | RF | APOE-?2 | 33576571 |
| 2211 | Alzheimer's Disease | Other polymorphisms | R487C | Human | CYP2B6 | RF | APOE-?2 | 33576571 |
| 1919 | Alzheimer's Disease | Other polymorphisms | Q172H | Human | CYP2B6 | RF | APOE-?3 | 33576571 |
| 3233 | Alzheimer's Disease | Other polymorphisms | Human | CYP2D6 | RF | CYP2D6B allele; in the Lewy body variant of AD | 7818242 | |
| 3234 | Alzheimer's Disease | Other polymorphisms | Human | CYP46A1 | RF | CYP46A1 gene variations | 19286353 | |
| 2137 | Alzheimer's Disease | Other polymorphisms | Human | CYP46A1 | RF | Overall; Genotype:TT; dominant mode | 29516283 | |
| 2688 | Alzheimer's Disease | Other polymorphisms | Human | CYP46A1 | RF | APOE ε4 carrier; Genotype:TT; dominant mode | 29516283 | |
| 2636 | Alzheimer's Disease | Other polymorphisms | Human | CYP46A1 | RF | APOE ε4 carrier; Genotype:CC; additive model | 29516283 | |
| 2136 | Alzheimer's Disease | Other polymorphisms | Human | CYP46A1 | RF | Overall; Genotype:TC; logistic regression model | 29516283 | |
| 2665 | Alzheimer's Disease | Other polymorphisms | Human | CYP46A1 | RF | APOE ε3/ε4; Genotype:TT; dominant mode | 29516283 | |
| 2594 | Alzheimer's Disease | Other polymorphisms | Human | CYP46A1 | RF | APOE ε3/ε4; Genotype:CC; additive model | 29516283 | |
| 3120 | Alzheimer's Disease | Other polymorphisms | Human | CYP46A1 | RF | APOE ε4 carrier; Genotype:CC | 29516283 | |
| 2459 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | DCC | RF | 27455347 | ||
| 629 | Alzheimer's Disease | Other polymorphisms | K180R | Human | DDIT4L | PF | APOE-?2 | 33576571 |
| 1842 | Parkinson disease | Other polymorphisms | Hemizygous 22q11.2 deletions | Human | DGCR8 | RF | 24018986 | |
| 1841 | Parkinson disease | Other polymorphisms | Hemizygous 22q11.2 deletions | Human | DGCR8 | RF | 24018986 | |
| 3724 | Alzheimer's Disease | Other polymorphisms | heterozygous missense R263H,the αKGDHc mutational profile | Human | DLD gene | RF | 33917565 | |
| 3238 | Tourette Syndrome | Other polymorphisms | Human | DRD2 | RF | 20431429 | ||
| 3239 | Parkinson disease | Other polymorphisms | Human | EMTP variation | RF | 30675927 | ||
| 549 | Alzheimer's Disease | Other polymorphisms | P278S | Human | EPHA7 | PF | APOE-?2 | 33576571 |
| 2062 | Alzheimer's Disease | Other polymorphisms | I138V | Human | EPHA7 | RF | APOE-?3 | 33576571 |
| 2239 | Alzheimer's Disease | Other polymorphisms | noncoding deletion 1 (ESR1-NCD1) polymorphism | Human | ESR1 | RF | 20674091 | |
| 1999 | Alzheimer's Disease | Other polymorphisms | rs2234693 polymorphism | Human | ESR1 | RF | 20674091 | |
| 3017 | Alzheimer's Disease | Other polymorphisms | Human | ESR1 and ESR2 | RF | the genetic profile created with the combination of the less represented alleles of these SNPs (expressed as XPAA) | 24052609 | |
| 3021 | Alzheimer's Disease | Other polymorphisms | H95Q | Human | FAM107B | RF | APOE-?2 | 33576571 |
| 2584 | Alzheimer's Disease | Other polymorphisms | E546Q | Human | FAM71E2 | RF | APOE-?3 | 33576571 |
| 2294 | Alzheimer's Disease | Other polymorphisms | R69C | Human | FOXN1 | RF | APOE-?2 | 33576571 |
| 3245 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | FUS | RF | 28054830 | ||
| 2685 | Alzheimer's Disease | Other polymorphisms | Human | G-308A( TNF-alpha gene) | RF | A-allele | 18992723 | |
| 3246 | Alzheimer's Disease | Other polymorphisms | Human | GAB2 | RF | ApoE epsilon4 non-carriers | 19276544 | |
| 3249 | Alzheimer's Disease | Other polymorphisms | Human | GALR3 | RF | 29177109 | ||
| 2518 | Alzheimer's Disease | Other polymorphisms | T209M | Human | GAMT | RF | APOE-?2 | 33576571 |
| 2043 | Alzheimer's Disease | Other polymorphisms | T209M | Human | GAMT | RF | APOE-?3 | 33576571 |
| 3250 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | GARS | RF | 30661401 | ||
| 3254 | Parkinson disease | Other polymorphisms | N370S,L444P | Human | GBA | RF | Patients with early-onset were more likely to carry GBA mutations than those with late-onset | 26868973 |
| 3259 | Dementia with Lewy bodies | Other polymorphisms | Human | GBA | RF | 18332251 | ||
| 3251 | Dementia with Lewy bodies | Other polymorphisms | Human | GBA | RF | 27723861 | ||
| 2944 | Parkinson disease | Other polymorphisms | N370S | Human | GBA | RF | 22812582 | |
| 3256 | Parkinson disease | Other polymorphisms | Heterozygous mutations | Human | GBA | RF | 26000814 | |
| 3099 | Parkinson disease | Other polymorphisms | L444P mutation | Human | GBA | RF | 20131388 | |
| 2767 | Parkinson disease | Other polymorphisms | N188S, P201H, R257Q, S271G, and L444P | Human | GBA | RF | 22387070 | |
| 2990 | Lewy Body Disease | Other polymorphisms | P.E365K rs2230288 | Human | GBA | RF | 34308904 | |
| 3253 | Dementia with Lewy bodies | Other polymorphisms | Human | GBA | RF | 27027900 | ||
| 3258 | Parkinson disease | Other polymorphisms | L444P,N370S,R120W,R47X,R131C | Human | GBA | RF | 30765263 | |
| 3836 | Parkinson disease | Other polymorphisms | R163Q,L444P,R120W | Human | GBA | RF | 34951095 | |
| 3063 | Parkinson disease | Other polymorphisms | p.K198E | Human | GBA | RF | 30765263 | |
| 3255 | Parkinson disease | Other polymorphisms | Heterozygous mutations | Human | GBA | RF | strong risk factors in FPD, especially for autosomal dominant PD | 24126159 |
| 3096 | Parkinson disease | Other polymorphisms | L444P,RecNciI,R120W | Human | GBA | RF | 17702778 | |
| 3252 | Dementia with Lewy bodies | Other polymorphisms | Human | GBA | RF | 27312774 | ||
| 3257 | Parkinson disease | Other polymorphisms | N370S,L444P | Human | GBA | RF | 30765263 | |
| 3095 | Dementia with Lewy bodies | Other polymorphisms | Human | GBA1 | RF | 23588557 | ||
| 2773 | Parkinson disease | Other polymorphisms | non-N370S mutation | Human | GBA1 | RF | non-N370S mutations associated with Gaucher disease | 22968580 |
| 3107 | Alzheimer's Disease | Other polymorphisms | S364F;S432F | Human | GORASP2 | RF | APOE-?2 | 33576571 |
| 2737 | Parkinson disease | Other polymorphisms | Human | GP1BA | RF | 33021140 | ||
| 2213 | Parkinson disease | Other polymorphisms | Human | GP6 | RF | 33021140 | ||
| 601 | Alzheimer's Disease | Other polymorphisms | C14F | Human | GPIHBP1 | PF | APOE-?2 | 33576571 |
| 3047 | Alzheimer's Disease | Other polymorphisms | T589M | Human | GPR37 | RF | APOE-?2 | 33576571 |
| 3671 | Frontotemporal Lobar Degeneration | Other polymorphisms | Human | GRN | RF | FTLD with TAR DNA-binding protein (TDP-43) inclusions | 20154673 | |
| 3263 | Frontotemporal Lobar Degeneration | other polymorphisms | Cys139Arg | Human | GRN | RF | 24503614 | |
| 3018 | Alzheimer's Disease | Other polymorphisms | A86T;A114T;A129T;A78T;A78T;A78T;A78T;A95T;A89T;A89T | Human | GSN | RF | APOE-?2 | 33576571 |
| 2867 | Alzheimer's Disease | Other polymorphisms | GSTM1 null deletions | Human | GSTM1 | RF | 29072550 | |
| 2498 | Alzheimer's Disease | Other polymorphisms | null genotype | Human | GSTM1 | RF | 22381228 | |
| 3264 | Alzheimer's Disease | Other polymorphisms | GSTP1 polymorphism V allele | Human | GSTP1 | RF | mainly in the presence of the apoE 4 allele | 18298341 |
| 2225 | Alzheimer's Disease | Other polymorphisms | GSTT1 null deletions | Human | GSTT1 | RF | 29072550 | |
| 1412 | Amyotrophic Lateral Sclerosis | Other polymorphisms | CG genotype | Human | H63D | RF | 33070529 | |
| 587 | Alzheimer's Disease | Other polymorphisms | I496V;I471V;I479V | Human | HAP1 | PF | APOE-?3 | 33576571 |
| 591 | Alzheimer's Disease | Other polymorphisms | A505V;A480V;A488V | Human | HAP1 | PF | APOE-?3 | 33576571 |
| 3265 | Alzheimer's Disease | Other polymorphisms | Human | hemochromatosis (HFE) | RF | 27081498 | ||
| 3267 | Parkinson disease | Other polymorphisms | C282Y variant allele | Human | HFE | RF | 16824219 | |
| 3266 | Parkinson disease | Other polymorphisms | C282Y variant allele | Human | HFE | RF | 16824219 | |
| 1437 | Alzheimer's Disease | Other polymorphisms | Human | HLA-A24 | RF | 18936542 | ||
| 2488 | Alzheimer's Disease | Other polymorphisms | C allele homozygosity | Human | HLA-DRB1 | RF | under a recessive model in the total sample | 29190991 |
| 2934 | Alzheimer's Disease | Other polymorphisms | GM 17/17 genotype | Human | Ig γ marker (GM) allotypes | RF | encoded by highly polymorphic IGHG genes on chromosome 14q32 | 32709662 |
| 2628 | Alzheimer's Disease | Other polymorphisms | P287L;P325L | Human | IGFALS | RF | APOE-?3 | 33576571 |
| 2691 | Alzheimer's Disease | Other polymorphisms | (-511 C/T) | Human | IL-1 beta promoter polymorphism | RF | APOE4 presence:APOE4 yes | 18717723 |
| 2205 | Alzheimer's Disease | Other polymorphisms | (-511 C/T) | Human | IL-1 beta promoter polymorphism | RF | APOE4 presence:APOE4 no | 18717723 |
| 2063 | Alzheimer's Disease | Other polymorphisms | (-511 C/T) | Human | IL-1 beta promoter polymorphism | RF | APOE4 presence:No stratified | 18717723 |
| 3270 | Alzheimer's Disease | Other polymorphisms | -511C/-31C/1-repetition VNTR haplotype | Human | IL-1 genes cluster | RF | 22498095 | |
| 831 | Alzheimer's Disease | Other polymorphisms | -511C/-31T/2-repetitions VNTR haplotype | Human | IL-1 genes cluster | PF | 22498095 | |
| 628 | Alzheimer's Disease | Other polymorphisms | A358V | Human | INO80D | PF | APOE-?2 | 33576571 |
| 1932 | Alzheimer's Disease | Other polymorphisms | I874S | Human | ITGA2B | RF | APOE-?3 | 33576571 |
| 1970 | Parkinson disease | Other polymorphisms | Human | ITGB5 | RF | 33021140 | ||
| 3810 | Lewy Body Disease | Other polymorphisms | R869C mutation | Human | KIF17 | RF | 34124335 | |
| 3078 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | KIF5A | RF | 27455347 | ||
| 3124 | Alzheimer's Disease | Other polymorphisms | A1178T | Human | LAMA2 | RF | APOE-?3 | 33576571 |
| 2215 | Alzheimer's Disease | Other polymorphisms | R619H | Human | LAMA2 | RF | APOE-?2 | 33576571 |
| 535 | Alzheimer's Disease | Other polymorphisms | G600R | Human | LAMA2 | PF | APOE-?2 | 33576571 |
| 489 | Alzheimer's Disease | Other polymorphisms | lhcgr2 C-allele | Human | LHCGR | PF | carrying an APOE epsilon4 allele | 18439297 |
| 2418 | Alzheimer's Disease | Other polymorphisms | P1428L | Human | LPA | RF | APOE-?2 | 33576571 |
| 3775 | Amyotrophic Lateral Sclerosis | Other polymorphisms | c.1721G>A, p.R574Q; c.1182A>T, p.R394S; and c.1681C>T, p.R561C | Human | LRP10 | RF | 32690342 | |
| 656 | Alzheimer's Disease | Other polymorphisms | G187A | Human | LRRC17 | PF | APOE-?2 | 33576571 |
| 2005 | Alzheimer's Disease | Other polymorphisms | K119E | Human | LRRC17 | RF | APOE-?3 | 33576571 |
| 783 | Alzheimer's Disease | Other polymorphisms | G187A | Human | LRRC17 | PF | APOE-?3 | 33576571 |
| 2098 | Alzheimer's Disease | Other polymorphisms | A145E | Human | LRRC2 | RF | APOE-?2 | 33576571 |
| 2904 | Parkinson disease | Other polymorphisms | Gly2385Arg variant | Human | LRRK2 | RF | 18201193 | |
| 3281 | Parkinson disease | Other polymorphisms | T4939A (S1647T) | Human | LRRK2 | RF | 21167764 | |
| 2981 | Parkinson disease | Other polymorphisms | G2385R polymorphism | Human | LRRK2 | RF | 23624603 | |
| 2335 | Parkinson disease | Other polymorphisms | G2385R variant (rs34778348) | Human | LRRK2 | RF | 19854095 | |
| 3872 | Parkinson disease | Other polymorphisms | Human | LRRK2 | RF | 33742109 | ||
| 3280 | Multiple System Atrophy | Other polymorphisms | p.Ile1371Val variant | Human | LRRK2 | RF | 29480226 | |
| 3112 | Parkinson disease | Other polymorphisms | G2019S mutation | Human | LRRK2 | RF | reater frequency of the G2019S mutation in Jewish than in non-Jewish cases with Parkinson disease | 17050822 |
| 2504 | Parkinson disease | Other polymorphisms | Gly2386Arg variant | Human | LRRK2 | RF | 17019612 | |
| 2514 | Parkinson disease | Other polymorphisms | Arg1628Pro variant | Human | LRRK2 | RF | 18716801 | |
| 2888 | Parkinson disease | Other polymorphisms | R1628P variant | Human | LRRK2 | RF | 19672984 | |
| 2548 | Parkinson disease | Other polymorphisms | Gly2388Arg variant | Human | LRRK2 | RF | 16633828 | |
| 3282 | Parkinson disease | Other polymorphisms | Gly2387Arg variant | Human | LRRK2 | RF | 17960808 | |
| 3141 | Parkinson disease | Other polymorphisms | R1628P variant | Human | LRRK2 | RF | 19699188 | |
| 2327 | Parkinson disease | Other polymorphisms | Homozygous S1647T genotype (AA) | Human | LRRK2 | RF | 20629711 | |
| 2487 | Parkinson disease | Other polymorphisms | Gly2388Arg variant | Human | LRRK2 | RF | 20673920 | |
| 3855 | Parkinson disease | Other polymorphisms | R1441G mutation | Human | LRRK2 | RF | 34060004 | |
| 2511 | Parkinson disease | Other polymorphisms | A419V variant | Human | LRRK2 | RF | especially in early-onset patients | 26234753 |
| 2800 | Alzheimer's Disease | Other polymorphisms | P477A;P803A;P477A;P424A;P424A | Human | LTBP1 | RF | APOE-?2 | 33576571 |
| 631 | Alzheimer's Disease | Other polymorphisms | E146K | Human | LTBP1 | PF | APOE-?3 | 33576571 |
| 2801 | Alzheimer's Disease | Other polymorphisms | P683Q;P1009Q;P683Q;P630Q;P630Q | Human | LTBP1 | RF | APOE-?2 | 33576571 |
| 3049 | Frontotemporal Lobar Degeneration | other polymorphisms | Human | MAPT | RF | H2H2 vs. H1H2 + H1H1 | 16410051 | |
| 2568 | Alzheimer's Disease | Other polymorphisms | p.A152T | Human | MAPT | RF | 22556362 | |
| 3285 | Frontotemporal Dementia | Other polymorphisms | Human | MAPT | RF | a rare microtubule-associated protein tau (MAPT) sequence variant, c.454G>A (p.A152T) | 23518664 | |
| 2782 | Frontotemporal Dementia | Other polymorphisms | p.A152T | Human | MAPT | RF | 22556362 | |
| 3985 | Amyotrophic Lateral Sclerosis | Other polymorphisms | haplotype GGAGCA (H1b) | Human | MAPT | RF | 38002967 | |
| 2746 | Frontotemporal Dementia | Other polymorphisms | Human | MAPT H2 haplotype | RF | APOE e4 negatives | 16410051 | |
| 2332 | Frontotemporal Dementia | Other polymorphisms | Human | MAPT H2 haplotype | RF | 16410051 | ||
| 2437 | Frontotemporal Dementia | Other polymorphisms | Human | MAPT H2H3 genetype | RF | APOE e4 negatives | 16410051 | |
| 2411 | Alzheimer's Disease | Other polymorphisms | p.V92M (rs2228479) | Human | MC1R | RF | 28059796 | |
| 3287 | Parkinson disease | Other polymorphisms | Arg151Cys polymorphism | Human | MC1R | RF | 19194882 | |
| 3286 | Parkinson disease | Other polymorphisms | Arg151Cys polymorphism | Human | MC1R | RF | 19194882 | |
| 3776 | Amyotrophic Lateral Sclerosis | Other polymorphisms | c.343G>A (p. V115M) and c.695T>C (p.L232P) | Human | MFSD8 | RF | 33226711 | |
| 3048 | Alzheimer's Disease | Other polymorphisms | T265I | Human | MGME1 | RF | APOE-?2 | 33576571 |
| 768 | Alzheimer's Disease | Other polymorphisms | I141M | Human | MIA2 | PF | APOE-?3 | 33576571 |
| 573 | Alzheimer's Disease | Other polymorphisms | P216S | Human | MIA2 | PF | APOE-?3 | 33576571 |
| 3289 | Alzheimer's Disease | Other polymorphisms | Human | MIEF1 | RF | 29177109 | ||
| 1992 | Alzheimer's Disease | Other polymorphisms | C677T polymorphism | Human | MTHFR | RF | without APOE epsilon4 alleles | 20600372 |
| 2771 | Alzheimer's Disease | Other polymorphisms | A1298C mutation | Human | MTHFR | RF | AA genotype | 23659764 |
| 3844 | Parkinson disease | Other polymorphisms | Human | MTPAP | RF | 34394198 | ||
| 2402 | Alzheimer's Disease | Other polymorphisms | M219V | Human | MYEOV | RF | APOE-?2 | 33576571 |
| 3296 | Motor Neuron Disease | other polymorphisms | Human | NEFH | RF | Genotype: SS | 14722583 | |
| 2614 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | NEK1 | RF | 27455347 | ||
| 3094 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | NEK1 | RF | 27455347 | ||
| 2613 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | NEK1 | RF | 27455347 | ||
| 2689 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | NEK1 | RF | 27455347 | ||
| 1330 | Alzheimer's Disease | Other polymorphisms | T allele | Human | neprilysin (NEP) | RF | 20376800 | |
| 3297 | Amyotrophic Lateral Sclerosis | other polymorphisms | Human | NIPA1 | RF | 22378146 | ||
| 3298 | Parkinson disease | Other polymorphisms | P268S variant | Human | NOD2 | RF | associated with late-onset PD | 23651603 |
| 672 | Alzheimer's Disease | Other polymorphisms | M475T | Human | NOP56 | PF | APOE-?2 | 33576571 |
| 762 | Alzheimer's Disease | Other polymorphisms | M475T | Human | NOP56 | PF | APOE-?3 | 33576571 |
| 3299 | Alzheimer's Disease | Other polymorphisms | G894T polymorphism G/G genotype | Human | NOS3 | RF | 20505439 | |
| 1333 | Alzheimer's Disease | Other polymorphisms | Glu298Asp polymorphism Glu/Glu genotype | Human | NOS3 | RF | in the APOE epsilon 4 noncarriers | 18183499 |
| 1332 | Alzheimer's Disease | Other polymorphisms | Glu298Asp polymorphism Glu allele | Human | NOS3 | RF | in the APOE epsilon 4 noncarriers | 18183499 |
| 1966 | Alzheimer's Disease | Other polymorphisms | 609 T allele | Human | NQO1 | RF | 18253865 | |
| 711 | Alzheimer's Disease | Other polymorphisms | 609 C/C genotype | Human | NQO1 | PF | significant difference in the APOE epsilon4 non-carriers | 18253865 |
| 2626 | Alzheimer's Disease | Other polymorphisms | R1681C | Human | NUMA1 | RF | APOE-?2 | 33576571 |
| 2652 | Alzheimer's Disease | Other polymorphisms | A794G | Human | NUMA1 | RF | APOE-?2 | 33576571 |
| 2475 | Alzheimer's Disease | Other polymorphisms | C27F | Human | OPRD1 | RF | APOE-?2 | 33576571 |
| 2286 | Alzheimer's Disease | Other polymorphisms | C27F | Human | OPRD1 | RF | APOE-?3 | 33576571 |
| 2216 | Alzheimer's Disease | Other polymorphisms | I59T | Human | OR1S2 | RF | APOE-?2 | 33576571 |
| 2273 | Alzheimer's Disease | Other polymorphisms | V225I | Human | OR1S2 | RF | APOE-?2 | 33576571 |
| 671 | Alzheimer's Disease | Other polymorphisms | I39V | Human | OR52E6 | PF | APOE-?2 | 33576571 |
| 649 | Alzheimer's Disease | Other polymorphisms | I159V | Human | OR52E6 | PF | APOE-?2 | 33576571 |
| 640 | Alzheimer's Disease | Other polymorphisms | F48L | Human | OR52E6 | PF | APOE-?2 | 33576571 |
| 652 | Alzheimer's Disease | Other polymorphisms | M199R | Human | OR52E6 | PF | APOE-?2 | 33576571 |
| 657 | Alzheimer's Disease | Other polymorphisms | S95P | Human | OR52E6 | PF | APOE-?2 | 33576571 |
| 2953 | Parkinson disease | Other polymorphisms | Human | P2RY12 | RF | 33021140 | ||
| 3305 | Parkinson disease | Other polymorphisms | V56E, C212Y, deletion of exons 3/5 and 225delA | Human | PARK2 | RF | 12056932 | |
| 3307 | Parkinson disease | Other polymorphisms | Heterozygous deletion of exon 2 | Human | PARK2 | RF | 24729340 | |
| 3306 | Parkinson disease | Other polymorphisms | Heterozygous deletion of exon 2 | Human | PARK2 | RF | 24729340 | |
| 3308 | Parkinson disease | Other polymorphisms | Parkin haploinsufficiency | Human | PARKIN | RF | 19636047 | |
| 2386 | Parkinson disease | Other polymorphisms | 167S/N heterozygotes | Human | PARKIN | RF | 10511432 | |
| 2387 | Parkinson disease | Other polymorphisms | 167S/N heterozygotes | Human | PARKIN | RF | 10511432 | |
| 3812 | Lewy Body Disease | Other polymorphisms | Human | PD-PRS | RF | 34308904 | ||
| 2434 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | PEAK1 | RF | 27455347 | ||
| 638 | Alzheimer's Disease | Other polymorphisms | L221M | Human | PELO | PF | APOE-?3 | 33576571 |
| 572 | Alzheimer's Disease | Other polymorphisms | L221M | Human | PELO | PF | APOE-?2 | 33576571 |
| 2760 | Alzheimer's Disease | Other polymorphisms | G287R | Human | PGP | RF | APOE-?2 | 33576571 |
| 1869 | Parkinson disease | Other polymorphisms | p.G411S heterozygotes | Human | PINK1 | RF | 27807026 | |
| 3310 | Parkinson disease | Other polymorphisms | Heterozygous mutations | Human | PINK1 | RF | 16969854 | |
| 3311 | Alzheimer's Disease | Other polymorphisms | Human | PLA2G3 | RF | 20930276 | ||
| 3312 | Parkinson disease | Other polymorphisms | p.Asp331Tyr | Human | PLA2G6 | RF | 22213678 | |
| 3313 | Alzheimer's Disease | Other polymorphisms | Human | PLEKHG5 | RF | 29177109 | ||
| 695 | Alzheimer's Disease | Other polymorphisms | Q251X | Human | POMT1 | PF | APOE-?2 | 33576571 |
| 2106 | Amyotrophic Lateral Sclerosis | other polymorphisms | rs662 | Human | PON1 Q192R(major allele is Q) | RF | Dominant (RR and QR vs QQ) | 16822965 |
| 2631 | Alzheimer's Disease | Other polymorphisms | M218V | Human | PRAME | RF | APOE-?2 | 33576571 |
| 746 | Alzheimer's Disease | Other polymorphisms | P71A | Human | PRKAG3 | PF | APOE-?3 | 33576571 |
| 2588 | Alzheimer's Disease | Other polymorphisms | R340W | Human | PRKAG3 | RF | APOE-?2 | 33576571 |
| 3846 | Parkinson disease | Other polymorphisms | Human | PRKN | RF | 34434164 | ||
| 3871 | Parkinson disease | Other polymorphisms | Human | PRKN | RF | 33742109 | ||
| 1784 | Parkinson disease | Other polymorphisms | with single heterozygous?PRKN?mutations | Human | PRKN | RF | 33448283 | |
| 3316 | Creutzfeldt-Jakob disease | other polymorphisms | Human | PRNP | RF | Codon 129: Val homozygosity | 8707291 | |
| 3793 | Creutzfeldt-Jakob disease | Other polymorphisms | E200K mutation | Human | PRNP | RF | 33917419 | |
| 1964 | Creutzfeldt-Jakob disease | Other polymorphisms | rs1799990 | Human | PRNP | RF | 32949544 | |
| 2974 | Creutzfeldt-Jakob disease | other polymorphisms | Human | PRNP | RF | APOE?ε4 carriers | 21799773 | |
| 3878 | Prion disease | Other polymorphisms | moose | PRNP | RF | 34346562 | ||
| 2884 | Fatal familial insomnia (FFI) | Other polymorphisms | codon 129 Met | Human | PRNP | RF | 34667102 | |
| 3794 | Creutzfeldt-Jakob disease | Other polymorphisms | polymorphism M129V | Human | PRNP | RF | 33917419 | |
| 3022 | Alzheimer's Disease | Other polymorphisms | R9Q | Human | PRPH | RF | APOE-?2 | 33576571 |
| 2161 | Alzheimer's Disease | Other polymorphisms | R290C | Human | PRSS48 | RF | APOE-?2 | 33576571 |
| 3317 | Alzheimer's Disease | Other polymorphisms | Human | PS-1 | RF | 8930979 | ||
| 2415 | Alzheimer's Disease | Other polymorphisms | Human | PS-1 | RF | APOE ε4 | 10581373 | |
| 3105 | Alzheimer's Disease | Other polymorphisms | Human | PS-2 | RF | APOE ε4 | 10581373 | |
| 3320 | Dementia with Lewy bodies | Other polymorphisms | Human | PSEN1 | RF | 27312774 | ||
| 3322 | Alzheimer's Disease | Other polymorphisms | Human | PSEN2 | RF | 24927704 | ||
| 2233 | Alzheimer's Disease | Other polymorphisms | V39A | Human | PSMB7 | RF | APOE-?2 | 33576571 |
| 3101 | Alzheimer's Disease | Other polymorphisms | S288L | Human | PTBP1 | RF | APOE-?3 | 33576571 |
| 642 | Alzheimer's Disease | Other polymorphisms | P1164L;P1164L;P1315L;P1249L;P1314L;P1164L;P1164L | Human | PTCH1 | PF | APOE-?2 | 33576571 |
| 3091 | Alzheimer's Disease | Other polymorphisms | T364M;T270M | Human | QPCTL | RF | APOE-?2 | 33576571 |
| 3327 | Alzheimer's Disease | Other polymorphisms | Human | RCAN1 | RF | 26497675 | ||
| 3326 | Alzheimer's Disease | Other polymorphisms | Human | RCAN1 | RF | 26497675 | ||
| 2378 | Alzheimer's Disease | Other polymorphisms | I259T | Human | RIPK2 | RF | APOE-?2 | 33576571 |
| 3845 | Parkinson disease | Other polymorphisms | Human | RP11-305E6 | RF | 34394198 | ||
| 3330 | Multiple System Atrophy | Other polymorphisms | CAG repeat length | Human | SCA1 | RF | 29715545 | |
| 3331 | Multiple System Atrophy | Other polymorphisms | Human | SCA3 | RF | 17133518 | ||
| 3003 | Alzheimer's Disease | Other polymorphisms | K1347E | Human | SCAF11 | RF | APOE-?3 | 33576571 |
| 558 | Alzheimer's Disease | Other polymorphisms | R847H | Human | SCAF11 | PF | APOE-?2 | 33576571 |
| 1833 | Lewy Body Disease | Other polymorphisms | rs6825004 intronic | Human | SCARB2 | RF | 34308904 | |
| 3019 | Alzheimer's Disease | Other polymorphisms | A931P | Human | SEMA6A | RF | APOE-?2 | 33576571 |
| 2925 | Alzheimer's Disease | Other polymorphisms | M64T;M64T;M76T | Human | SERPINE2 | RF | APOE-?2 | 33576571 |
| 2309 | Alzheimer's Disease | Other polymorphisms | T143I | Human | SFTPB | RF | APOE-?2 | 33576571 |
| 2763 | Alzheimer's Disease | Other polymorphisms | P168L | Human | SH3D19 | RF | APOE-?3 | 33576571 |
| 595 | Alzheimer's Disease | Other polymorphisms | W326X | Human | SLC35G6 | PF | APOE-?2 | 33576571 |
| 617 | Alzheimer's Disease | Other polymorphisms | W326R | Human | SLC35G6 | PF | APOE-?2 | 33576571 |
| 770 | Parkinson disease | Other polymorphisms | 10-repeat allele of 3′VNTR | Human | SLC6A3 | PF | 24211691 | |
| 3333 | Amyotrophic Lateral Sclerosis | other polymorphisms | Human | SMN2 | RF | 22187232 | ||
| 3334 | Parkinson disease | Other polymorphisms | c.996delC (fsP330), p.L302P and p.R496L | Human | SMPD1 | RF | 26169695 | |
| 2330 | Alzheimer's Disease | Other polymorphisms | F4L | Human | SMPD4 | RF | APOE-?3 | 33576571 |
| 621 | Alzheimer's Disease | Other polymorphisms | R345G | Human | SMTNL1 | PF | APOE-?2 | 33576571 |
| 733 | Alzheimer's Disease | Other polymorphisms | R345G | Human | SMTNL1 | PF | APOE-?3 | 33576571 |
| 1971 | Parkinson disease | Other polymorphisms | Dinucleotide polymorphism (REP1) | Human | SNCA | RF | 18404644 | |
| 3838 | Parkinson disease | Other polymorphisms | intron 1 CGI region DNA methylation | Human | SNCA | RF | 33994928 | |
| 3843 | Parkinson disease | Other polymorphisms | Human | SNCA | RF | 34394198 | ||
| 3808 | Lewy Body Disease | Other polymorphisms | intron 1 CGI region DNA methylation | Human | SNCA | RF | 33994928 | |
| 1972 | Parkinson disease | Other polymorphisms | Dinucleotide polymorphism (REP1) | Human | SNCA | RF | 18404644 | |
| 2419 | Alzheimer's Disease | Other polymorphisms | V323M | Human | SNX27 | RF | APOE-?2 | 33576571 |
| 3336 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | SOD1 | RF | 24591609 | ||
| 3338 | Alzheimer's Disease | Other polymorphisms | Human | SORL1 | RF | 19368828 | ||
| 3339 | Amyotrophic Lateral Sclerosis | other polymorphisms | Human | SPG4 | RF | 16009903 | ||
| 3672 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | SPG7 mutations | RF | 32447552 | ||
| 3340 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | SQSTM1 | RF | 22972638 | ||
| 559 | Alzheimer's Disease | Other polymorphisms | R166M;R185M | Human | STEAP1B | PF | APOE-?2 | 33576571 |
| 1987 | Alzheimer's Disease | Other polymorphisms | Q7R polymorphism RR genotype | Human | STH | RF | especially in caucasian population, late‐onset AD subjects and studies with high quality | 28211174 |
| 2914 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | STX12 | RF | 27455347 | ||
| 1917 | Creutzfeldt-Jakob disease | Other polymorphisms | rs3747957 | Human | STX6(Syntaxin-6) | RF | 32949544 | |
| 3869 | Parkinson disease | Other polymorphisms | rs246814 | Human | SV2C | RF | 33760272 | |
| 596 | Alzheimer's Disease | Other polymorphisms | D369G | Human | SYTL2 | PF | APOE-?2 | 33576571 |
| 2858 | Alzheimer's Disease | Other polymorphisms | A137V | Human | SYTL2 | RF | APOE-?2 | 33576571 |
| 667 | Alzheimer's Disease | Other polymorphisms | T383M | Human | SYTL2 | PF | APOE-?2 | 33576571 |
| 2147 | Alzheimer's Disease | Other polymorphisms | I92V | Human | SYTL2 | RF | APOE-?3 | 33576571 |
| 639 | Alzheimer's Disease | Other polymorphisms | A211G | Human | SYTL2 | PF | APOE-?2 | 33576571 |
| 650 | Alzheimer's Disease | Other polymorphisms | M334V | Human | SYTL2 | PF | APOE-?2 | 33576571 |
| 2376 | Alzheimer's Disease | Other polymorphisms | M1V | Human | SYTL2 | RF | APOE-?3 | 33576571 |
| 3778 | Amyotrophic Lateral Sclerosis | Other polymorphisms | intermediate-length CAG/CAA repeat expansions | Human | TATA-box binding protein gene (TBP) | RF | 33377399 | |
| 2846 | Frontotemporal Lobar Degeneration | other polymorphisms | Human | tau | RF | tau Genotype:H1H2+H2H2;presence of APOE E2 allele | 12056929 | |
| 3927 | Alzheimer's Disease | Other polymorphisms | H2 haplotype | Human | tau | RF | 35348036 | |
| 2686 | Frontotemporal Lobar Degeneration | other polymorphisms | Human | tau | RF | tau Genotype:H1H1;absence of APOE E2 allele | 12056929 | |
| 3349 | Progressive Supranuclear Palsy | Other polymorphisms | Human | tau A0/A0 genotype | RF | 9708963 | ||
| 3348 | Progressive Supranuclear Palsy | Other polymorphisms | Human | tau A0/A0 genotype | RF | 9708963 | ||
| 3118 | Frontotemporal Lobar Degeneration | other polymorphisms | Human | tau,APOE | RF | tau A3,APOE ε4 | 11303757 | |
| 2971 | Alzheimer's Disease | Other polymorphisms | N1206S | Human | TBC1D4 | RF | APOE-?2 | 33576571 |
| 2367 | Alzheimer's Disease | Other polymorphisms | G256R | Human | TCF7 | RF | APOE-?2 | 33576571 |
| 3828 | Parkinson disease | Other polymorphisms | rare loss-of-function and damaging missense variants of TENM4; damaging missense variants of TENM4 alone | Human | TENM4 | RF | 33185019 | |
| 2535 | Alzheimer's Disease | Other polymorphisms | R455C | Human | TESK2 | RF | APOE-?2 | 33576571 |
| 2381 | Alzheimer's Disease | Other polymorphisms | S12T polymorphism | Human | TFAM | RF | 18430995 | |
| 3143 | Parkinson disease | Other polymorphisms | A rare heterozygous deletion over TH | Human | TH | RF | 20809526 | |
| 3350 | Alzheimer's Disease | Other polymorphisms | Human | THBS2 | RF | 29177109 | ||
| 2490 | Alzheimer's Disease | Other polymorphisms | L232P | Human | THG1L | RF | APOE-?2 | 33576571 |
| 643 | Alzheimer's Disease | Other polymorphisms | -196 to -174 del polymorphism | Human | TLR2 | PF | 26738351 | |
| 3673 | Frontotemporal Lobar Degeneration | Other polymorphisms | Human | TMEM106B | RF | FTLD with TAR DNA-binding protein (TDP-43) inclusions | 20154673 | |
| 1830 | Lewy Body Disease | Other polymorphisms | missense p.Met311Thr | Human | TMEM175 | RF | 34308904 | |
| 3355 | Alzheimer's Disease | Other polymorphisms | Human | TNFRSF1A, CDH1, CASP7, LRP1B and TG | RF | 26621834 | ||
| 1329 | Alzheimer's Disease | Other polymorphisms | G-308A polymorphism A-allele | Human | TNF-α | RF | in the APOE epsilon4 non-carriers | 18396294 |
| 1334 | Alzheimer's Disease | Other polymorphisms | G-308A polymorphism AA genotype | Human | TNF-α | RF | in the APOE epsilon4 non-carriers | 18396294 |
| 2770 | Alzheimer's Disease | Other polymorphisms | Human | TNF-α -308 | RF | AA vs. GG | 25647294 | |
| 2104 | Alzheimer's Disease | Other polymorphisms | Human | TNF-α -308 | RF | AA + AG vs. GG (dominant) | 25647294 | |
| 2295 | Alzheimer's Disease | Other polymorphisms | Human | TNF-α -308 | RF | A vs. G allele | 25647294 | |
| 2452 | Alzheimer's Disease | Other polymorphisms | Human | TNF-α -308 | RF | AA vs. AG | 25647294 | |
| 2766 | Alzheimer's Disease | Other polymorphisms | Human | TNF-α -308 | RF | AA vs. AG + GG (recessive) | 25647294 | |
| 3358 | Alzheimer's Disease | Other polymorphisms | rs2075650 polymorphisms | Human | TOMM40 | RF | 30443289 | |
| 2440 | Alzheimer's Disease | Other polymorphisms | rs71352238 CC genotype | Human | TOMM40 | RF | APOE ε4+ | 32725468 |
| 894 | Parkinson disease | Other polymorphisms | '523' variant | Human | TOMM40 | PF | carriage of longer '523' alleles | 34234128 |
| 3839 | Parkinson disease | Other polymorphisms | '523' variant | Human | TOMM40 | RF | carriage of shorter '523' alleles | 34234128 |
| 2585 | Alzheimer's Disease | Other polymorphisms | N122S | Human | TOX | RF | APOE-?2 | 33576571 |
| 739 | Alzheimer's Disease | Other polymorphisms | D10N | Human | TRAF3IP2 | PF | APOE-?3 | 33576571 |
| 594 | Alzheimer's Disease | Other polymorphisms | D10N | Human | TRAF3IP2 | PF | APOE-?2 | 33576571 |
| 2693 | Parkinson disease | Other polymorphisms | p.R47H substitution | Human | TREM2 | RF | 23800361 | |
| 3076 | Alzheimer's Disease | Other polymorphisms | R47H | Human | TREM2 | RF | APOE-?2 | 33576571 |
| 2907 | Alzheimer's Disease | Other polymorphisms | R47H | Human | TREM2 | RF | APOE-?3 | 33576571 |
| 3361 | Frontotemporal Dementia | Other polymorphisms | Human | TREM2 | RF | 29557178 | ||
| 2816 | Dementia with Lewy bodies | Other polymorphisms | p.R62H | Human | TREM2 | RF | 28003435 | |
| 2383 | Alzheimer's Disease | Other polymorphisms | p.R47H | Human | TREM2 | RF | 24439484 | |
| 811 | Alzheimer's Disease | Other polymorphisms | p.S144G | Human | TREML2 | PF | 24439484 | |
| 2804 | Alzheimer's Disease | Other polymorphisms | A12V | Human | TTC38 | RF | APOE-?2 | 33576571 |
| 2328 | Alzheimer's Disease | Other polymorphisms | T262I | Human | TTLL13 | RF | APOE-?2 | 33576571 |
| 2359 | Alzheimer's Disease | Other polymorphisms | A126T | Human | TTLL13 | RF | APOE-?2 | 33576571 |
| 2987 | Alzheimer's Disease | Other polymorphisms | S30I | Human | TXNRD3NB | RF | APOE-?2 | 33576571 |
| 3368 | Alzheimer's Disease | Other polymorphisms | Human | TYROBP | RF | 27658901 | ||
| 2068 | Frontotemporal Lobar Degeneration | other polymorphisms | Human | UBAP1 | RF | Haplotype:GCT | 19217189 | |
| 2031 | Frontotemporal Lobar Degeneration | other polymorphisms | Human | UBAP1 | RF | Haplotype:TGC | 19217189 | |
| 2069 | Frontotemporal Lobar Degeneration | other polymorphisms | Human | UBAP1 | RF | Haplotype:TGC | 19217189 | |
| 2232 | Alzheimer's Disease | Other polymorphisms | A68T | Human | UBASH3B | RF | APOE-?2 | 33576571 |
| 738 | Alzheimer's Disease | Other polymorphisms | C67G;C121G | Human | UGT3A1 | PF | APOE-?3 | 33576571 |
| 663 | Alzheimer's Disease | Other polymorphisms | C67G;C121G | Human | UGT3A1 | PF | APOE-?2 | 33576571 |
| 3370 | Amyotrophic Lateral Sclerosis | Other polymorphisms | zebrafish | VAPB | RF | 23446633 | ||
| 3369 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Mice | VAPB | RF | 23446633 | ||
| 3069 | Progressive Supranuclear Palsy | Other polymorphisms | Human | VEGF haplotypes(AGG) | RF | 20413880 | ||
| 3020 | Alzheimer's Disease | Other polymorphisms | R113S | Human | VSTM5 | RF | APOE-?2 | 33576571 |
| 3870 | Parkinson disease | Other polymorphisms | rs9638616 | Human | WBSCR17 | RF | 33760272 | |
| 2450 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | WDR49 | RF | 27455347 | ||
| 797 | Alzheimer's Disease | Other polymorphisms | Q273R | Human | WDR60 | PF | APOE-?3 | 33576571 |
| 622 | Alzheimer's Disease | Other polymorphisms | A263T | Human | YDJC | PF | APOE-?2 | 33576571 |
| 2182 | Alzheimer's Disease | Other polymorphisms | Q42H | Human | ZAR1 | RF | APOE-?3 | 33576571 |
| 2638 | Alzheimer's Disease | Other polymorphisms | Q42H | Human | ZAR1 | RF | APOE-?2 | 33576571 |
| 584 | Alzheimer's Disease | Other polymorphisms | P15A | Human | ZCCHC9 | PF | APOE-?2 | 33576571 |
| 2616 | Alzheimer's Disease | Other polymorphisms | T136K | Human | ZNF596 | RF | APOE-?2 | 33576571 |
| 2599 | Alzheimer's Disease | Other polymorphisms | Y701C;Y673C | Human | ZNF778 | RF | APOE-?2 | 33576571 |
| 2385 | Alzheimer's Disease | Other polymorphisms | S1193P | Human | ZNF804B | RF | APOE-?3 | 33576571 |
| 2493 | Alzheimer's Disease | Other polymorphisms | G375S | Human | ZNF90 | RF | APOE-?2 | 33576571 |
| 2451 | Amyotrophic Lateral Sclerosis | Other polymorphisms | Human | ZSCAN5B | RF | 27455347 |
|
All rights reserved: Institutes for Systems Genetics, West China Hospital
|